Neurovascular Devices Market: Global Industry Analysis and Forecast (2024-2030) by Device Type, Application, End User and Region

Global Neurovascular Devices Market size was valued at USD 2.82 Bn. in 2023 and is expected to reach USD 4.30 Bn. by 2030, at a CAGR of 6.2%.

Neurovascular Devices Market Overview

Neurovascular devices cater to critical conditions like ischemic stroke and cerebral aneurysm. These devices, including embolic coils, flow diversion stents, and thrombectomy tools, address the complexities of the brain's vasculature. TE Connectivity specializes in Minimally Invasive Access and delivery devices, offering precise solutions for neurovascular therapies and serving as a key global provider in this specialized field. As life expectancy rises globally, the demand for innovative solutions targeting prevalent conditions in aging populations, like neurovascular disorders, intensifies. Disorders like ischemic stroke and cerebral aneurysms present substantial threats to both quality of life and mortality rates. The Neurovascular Devices Market plays a pivotal role in addressing these challenges by providing essential medical devices tailored to diagnosing and treating these conditions. They include specialized tools for delivering embolic coils and flow diversion stents to prevent aneurysm rupture, as well as devices for clot removal in cerebral blood vessels. The intricate nature of the brain's vasculature demands precision and minimally invasive techniques to ensure patient safety. The Neurovascular Devices industry is experiencing growth due to various key drivers and trends. Primarily, the aging global population increases neurovascular disorder prevalence, necessitating innovative devices for conditions such as ischemic stroke and cerebral aneurysm. Technological advancements are pivotal, enabling sophisticated and minimally invasive device development, incorporating improved imaging for precise diagnosis and advanced materials for heightened efficacy and safety. Increasing adoption of neurothrombectomy devices and flow diversion stents drives market expansion, propelled by growing awareness among healthcare professionals and patients favoring early intervention with neurovascular devices. Research emphasis on novel therapies, aided by government healthcare initiatives, and industry growth through collaborations and acquisitions, augments market growth. The Neurovascular Devices Market thrives on innovation, disease prevalence, raised awareness, and strategic partnerships.Neurovascular Devices MarketTo know about the Research Methodology :- Request Free Sample Report

Neurovascular Devices Market Trends

Rapid Advancement and Adoption of Minimally Invasive Procedures and Devices The Neurovascular Devices Market witnesses a transformative trend through the rapid acceptance and advancements in minimally invasive procedures and devices, redefining the medical device landscape. Embraced by both medical practitioners and patients, these techniques minimize invasiveness compared to traditional surgeries, employing smaller incisions aided by imaging technologies and advanced devices, thereby reducing infection risks and recovery times. These minimally invasive devices, offering reduced pain and shorter hospital stays, epitomize progress in healthcare, propelled by continuous technological enhancements. This shift aligns with patient preferences for less invasive procedures, fostering the expansion of these techniques across diverse medical specialties and significantly impacting the evolution of the Market. Rapid advancements and widespread adoption of minimally invasive procedures and devices are steering a significant trend in the Neurovascular Devices Market. Surgeons now wield evolved instruments tailored to perform specialized tasks quickly due to the diverse range of designs often customized by influential opinion leaders. Integrated miniaturized sensors in these devices provide vital anatomical feedback, aiding in procedures with limited visibility. The increase of robot-assisted surgeries, offering precision without direct visualization, stands as a swiftly evolving technology, significantly improving surgical accuracy while minimizing patient trauma and recovery time. Despite hurdles like high equipment costs and specialized training requirements, these advancements persist, propelled by ongoing technological innovations in visualization methods such as high-resolution imaging and real-time anatomical modeling. The seamless integration of robotics, advanced imaging, and minimally invasive techniques across various surgeries marks an influential trend driving the future landscape of the Neurovascular Devices industry.

Neurovascular Devices Market Dynamics

The escalating prevalence of neurovascular disorders due to the aging global population boosts Market Growth The escalating prevalence of neurovascular disorders is predominantly associated with the aging global population driving the Neurovascular Devices Market. This category incorporates various irregularities within the blood vessels supplying or within the brain and spinal cord, including ischemic stroke and cerebral aneurysm, both severe and potentially fatal conditions. These disorders often arise due to arterial narrowing, resulting in reduced blood flow to the brain, heightening the risks of strokes. The surge in these conditions has led to the advancement of innovative technologies and surgical techniques, a domain where healthcare institutions such as Virginia Mason Franciscan Health and Dignity Health Neurological Institute lead the way. Advancements in technology and surgical methods have been alleviating the impact of neurovascular diseases. Interventions involving stents to widen constricted arteries, injection of materials into blood vessels to treat malformations or curb tumor blood supply, and microsurgical clipping for repairing brain aneurysms offer a diverse range of treatment options. This array of tools across radiological and surgical specializations significantly enhances physicians' abilities to safely address vascular issues impacting the brain and spine. Leading institutions like the Dignity Health Neurological Institute of Northern California offer state-of-the-art treatments for various neurovascular conditions, encompassing aneurysms, stenosis, and intracranial stenosis, employing innovative solutions from the Neurovascular Devices Market. The complexity of these disorders often presents sudden and severe symptoms, ranging from numbness and muscle weakness to headaches, seizures, and personality changes. Immediate evaluation and care are crucial, especially for potential stroke cases, necessitating prompt emergency treatment. Neurovascular diseases' causative factors are multifaceted, encompassing congenital conditions like arteriovenous malformations (AVMs) arising during fetal development, genetic predispositions, lifestyle habits, and various medical factors. Risk factors, akin to those for heart attacks including diabetes, high blood pressure, smoking, and high cholesterol, contribute to conditions such as carotid artery stenosis and ischemic strokes. Regulatory Landscape and Stringent Approval Processes Hamper Market Growth The Neurovascular Devices Market encounters a significant challenge due to stringent regulatory frameworks governing the introduction of new devices. These regulatory measures, overseen by various global bodies, demand rigorous adherence to safety and efficacy standards. Introducing innovative neurovascular devices involves extensive testing and clinical trials, elongating the approval process and extending the time-to-market. This prolonged journey necessitates substantial financial investments. The evolving and diverse regulatory requisites across different regions heighten complexity, requiring companies to navigate multifaceted approval procedures for global market entry. These intricate compliance protocols pose obstacles, hindering the pace of innovation and delaying access to advanced neurovascular solutions for healthcare providers and patients worldwide. The stringent regulatory landscape extends developmental timelines, elevates costs, and impedes the industry's swift introduction of cutting-edge solutions for neurovascular conditions.

Neurovascular Devices Market Segment Analysis

Based on Device Type, the Neurovascular Devices Market is segmented into Cerebral Angiography Systems, Neurothrombectomy Devices, Embolic Coils and Flow Diverters, Carotid Stents and Embolic Protection Systems, Microcatheters and Balloon Catheters and Others. Cerebral Angiography Systems dominated the Market in 2023. Cerebral Angiography Systems stand out as a dominant device within the Market due to their ability to diagnose and treat neurological conditions. These systems are a pivotal component in angiographic procedures, using X-ray imaging and contrast material to produce detailed pictures of blood vessels in the brain. Employing a catheter inserted into an artery in the leg or arm, these systems allow for intricate examination and treatment within a single procedure, aiding in the detection of abnormalities such as aneurysms or atherosclerosis. The capability to deliver highly precise, clear, and accurate images of cerebral blood vessels enhances diagnostic accuracy, potentially eliminating the necessity for more invasive surgical interventions. While cerebral angiography systems are minimally invasive, their integral role in providing real-time blood flow visualization and aiding in planning effective treatments makes them a cornerstone in addressing neurological issues, positioning them as an essential and dominant device Type in the Neurovascular Devices Market. Neurothrombectomy Devices are expected to have a significant growth rate for the Market over the forecast period. Neurothrombectomy Devices play a crucial role in the Neurovascular Devices Market, serving as instrumental tools in the management of neurovascular disorders. These devices are specifically designed for thrombectomy procedures, aiming to remove blood clots or thrombi from blood vessels within the brain. The prevalence of conditions such as ischemic stroke, often caused by blood clots blocking crucial vessels, has heightened the significance of neurothrombectomy devices. Utilizing advanced technologies, these devices navigate the intricate vasculature of the brain to precisely target and extract thrombi, restoring blood flow and mitigating the impact of strokes.

Neurovascular Devices Market1Neurovascular Devices Market Regional Insights

North America held the largest Market share and is expected to dominate the Neurovascular Devices Market growth. North America asserts dominance in the Market due to several key factors. The region boasts a robust healthcare infrastructure with advanced medical facilities and a high adoption rate of innovative medical technologies. This technological ability fosters a conducive environment for the development and uptake of neurovascular devices. The presence of well-established regulatory frameworks, such as the FDA in the United States, ensures stringent but structured approval processes, instilling confidence in the safety and efficacy of these devices. North America's healthcare expenditure is substantial, facilitating greater investment in research and development for neurovascular devices. This financial backing encourages innovation and the introduction of cutting-edge technologies, further propelling market growth. The region also benefits from a higher prevalence of neurovascular disorders, including stroke and aneurysms, which drives the demand for advanced medical devices to address these conditions. The strong presence of key market players and collaborations between industry stakeholders, academic institutions, and research organizations in North America contribute to the market's dominance. These collaborations foster innovation, accelerate product development, and enhance the commercialization of neurovascular devices. Overall, North America's favorable regulatory environment, technological advancements, robust healthcare infrastructure, high healthcare expenditure, and prevalence of neurovascular disorders collectively position it as the dominant region in the Neurovascular Devices Market. North America's dominance in the 2023 Market, holding a 32.44% share, owes to key players such as Stryker Corporation, Penumbra, Inc., Johnson and Johnson, and Merit Medical Systems, Inc. Cerus Endovascular Ltd.'s CE Mark approval for the 0.021-inch Contour Neurovascular System in April 2023 expanded treatment options for saccular intracranial aneurysms. The U.S. Catheters Market size, inclusive of the Neurovascular Devices segment, experienced steady growth from 2018 to 2023, reflecting a significant contribution to the overall expansion of the Neurovascular Devices Market in North America.

Neurovascular Devices Market2Neurovascular Device Market Scope: Inquire before buying

Global Neurovascular Device Market
Report Coverage Details
Base Year: 2023 Forecast Period: 2024-2030
Historical Data: 2018 to 2023 Market Size in 2023: US $ 2.82 Bn.
Forecast Period 2024 to 2030 CAGR: 6.2% Market Size in 2030: US $ 4.30 Bn.
Segments Covered: By Device Type Cerebral Angiography Systems Neurothrombectomy Devices Embolic Coils and Flow Diverters Carotid Stents and Embolic Protection Systems Microcatheters and Balloon Catheters Others
By Application Ischemic Strokes Brain Aneurysms Arteriovenous Malformations (AVMs) Carotid Artery Stenosis Others
By End User Hospitals and Clinics Ambulatory Surgical Centers (ASCs) Diagnostic Centers Others

Global Neurovascular Device Market, by Region

North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)

Neurovascular Devices Market Key Players

1. Medtronic plc (Dublin, Ireland) 2. Johnson & Johnson (New Brunswick, New Jersey, USA) 3. Stryker Corporation (Kalamazoo, Michigan, USA) 4. Terumo Corporation (Tokyo, Japan) 5. Abbott Laboratories (Abbott Park, Illinois, USA) Neurovascular Devices Manufacturers in North America 1. Penumbra, Inc. (Alameda, California, USA) 2. Merit Medical Systems, Inc. (South Jordan, Utah, USA) Neurovascular Devices Manufacturers in Europe 1. Balt Extrusion (Montmorency, France) 2. Acandis GmbH (Pforzheim, Germany) 3. ArtVentive Medical Group, Inc. (Carlsbad, California, USA) 4. Spiegelberg GmbH & Co. KG (Hamburg, Germany) 5. EndoShape, Inc. (Aliso Viejo, California, USA) 6. Penumbra Europe GmbH (Alsbach-Hähnlein, Germany) Neurovascular Devices Manufacturers in Asia Pacific 1. Terumo Corporation (Tokyo, Japan) 2. MicroPort Scientific Corporation (Shanghai, China) 3. Medikit Co., Ltd. (Tokyo, Japan) 4. Penumbra Japan (Tokyo, Japan) 5. Asahi Intecc Co., Ltd. (Aichi, Japan) 6. Kaneka Corporation (Osaka, Japan)

Frequently Asked Questions:

1] What is the growth rate of the Global Neurovascular Devices Market? Ans. The Global Neurovascular Devices Market is growing at a significant rate of 6.2% during the forecast period. 2] Which region is expected to dominate the Global Neurovascular Devices Market? Ans. North America is expected to dominate the Neurovascular Devices Market during the forecast period. 3] What is the expected Global Neurovascular Devices Market size by 2030? Ans. The Neurovascular Devices Market size is expected to reach USD 4.30 Billion by 2030. 4] Which are the top players in the Global Neurovascular Devices Market? Ans. The major top players in the Global Neurovascular Devices Market are Medtronic plc (Dublin, Ireland),Johnson & Johnson (New Brunswick, New Jersey, USA),Stryker Corporation (Kalamazoo, Michigan, USA), Terumo Corporation (Tokyo, Japan) , Abbott Laboratories (Abbott Park, Illinois, USA) and Others. 5] What are the factors driving the Global Neurovascular Devices Market growth? Ans. Increasing Prevalence of neurovascular disorders and technological advancements are expected to drive market growth during the forecast period.
1. Neurovascular Devices Market: Research Methodology 2. Neurovascular Devices Market Introduction 2.1. Study Assumption and Market Definition 2.2. Scope of the Study 2.3. Executive Summary 3. Neurovascular Devices Market: Dynamics 3.1. Neurovascular Devices Market Trends by Region 3.1.1. North America Neurovascular Devices Market Trends 3.1.2. Europe Neurovascular Devices Market Trends 3.1.3. Asia Pacific Neurovascular Devices Market Trends 3.1.4. Middle East and Africa Neurovascular Devices Market Trends 3.1.5. South America Neurovascular Devices Market Trends 3.2. Neurovascular Devices Market Dynamics by Region 3.2.1. North America 3.2.1.1. North America Neurovascular Devices Market Drivers 3.2.1.2. North America Neurovascular Devices Market Restraints 3.2.1.3. North America Neurovascular Devices Market Opportunities 3.2.1.4. North America Neurovascular Devices Market Challenges 3.2.2. Europe 3.2.2.1. Europe Neurovascular Devices Market Drivers 3.2.2.2. Europe Neurovascular Devices Market Restraints 3.2.2.3. Europe Neurovascular Devices Market Opportunities 3.2.2.4. Europe Neurovascular Devices Market Challenges 3.2.3. Asia Pacific 3.2.3.1. Asia Pacific Neurovascular Devices Market Drivers 3.2.3.2. Asia Pacific Neurovascular Devices Market Restraints 3.2.3.3. Asia Pacific Neurovascular Devices Market Opportunities 3.2.3.4. Asia Pacific Neurovascular Devices Market Challenges 3.2.4. Middle East and Africa 3.2.4.1. Middle East and Africa Neurovascular Devices Market Drivers 3.2.4.2. Middle East and Africa Neurovascular Devices Market Restraints 3.2.4.3. Middle East and Africa Neurovascular Devices Market Opportunities 3.2.4.4. Middle East and Africa Neurovascular Devices Market Challenges 3.2.5. South America 3.2.5.1. South America Neurovascular Devices Market Drivers 3.2.5.2. South America Neurovascular Devices Market Restraints 3.2.5.3. South America Neurovascular Devices Market Opportunities 3.2.5.4. South America Neurovascular Devices Market Challenges 3.3. PORTER’s Five Forces Analysis 3.4. PESTLE Analysis 3.5. Technology Roadmap 3.6. Regulatory Landscape by Region 3.6.1. North America 3.6.2. Europe 3.6.3. Asia Pacific 3.6.4. Middle East and Africa 3.6.5. South America 3.7. Key Opinion Leader Analysis For Neurovascular Devices Market 3.8. Analysis of Government Schemes and Initiatives For Neurovascular Devices Market 4. Neurovascular Devices Market: Global Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 4.1. Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 4.1.1. Cerebral Angiography Systems 4.1.2. Neurothrombectomy Devices 4.1.3. Embolic Coils and Flow Diverters 4.1.4. Carotid Stents and Embolic Protection Systems 4.1.5. Microcatheters and Balloon Catheters 4.1.6. Others 4.2. Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 4.2.1. Ischemic Strokes 4.2.2. Brain Aneurysms 4.2.3. Arteriovenous Malformations (AVMs) 4.2.4. Carotid Artery Stenosis 4.2.5. Others 4.3. Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 4.3.1. Hospitals and Clinics 4.3.2. Ambulatory Surgical Centers (ASCs) 4.3.3. Diagnostic Centers 4.3.4. Others 4.4. Neurovascular Devices Market Size and Forecast, by Region (2023-2030) 4.4.1. North America 4.4.2. Europe 4.4.3. Asia Pacific 4.4.4. Middle East and Africa 4.4.5. South America 5. North America Neurovascular Devices Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 5.1. North America Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 5.1.1. Cerebral Angiography Systems 5.1.2. Neurothrombectomy Devices 5.1.3. Embolic Coils and Flow Diverters 5.1.4. Carotid Stents and Embolic Protection Systems 5.1.5. Microcatheters and Balloon Catheters 5.1.6. Others 5.2. North America Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 5.2.1. Ischemic Strokes 5.2.2. Brain Aneurysms 5.2.3. Arteriovenous Malformations (AVMs) 5.2.4. Carotid Artery Stenosis 5.2.5. Others 5.3. North America Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 5.3.1. Hospitals and Clinics 5.3.2. Ambulatory Surgical Centers (ASCs) 5.3.3. Diagnostic Centers 5.3.4. Others 5.4. North America Neurovascular Devices Market Size and Forecast, by Country (2023-2030) 5.4.1. United States 5.4.1.1. United States Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 5.4.1.1.1. Cerebral Angiography Systems 5.4.1.1.2. Neurothrombectomy Devices 5.4.1.1.3. Embolic Coils and Flow Diverters 5.4.1.1.4. Carotid Stents and Embolic Protection Systems 5.4.1.1.5. Microcatheters and Balloon Catheters 5.4.1.1.6. Others 5.4.1.2. United States Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 5.4.1.2.1. Ischemic Strokes 5.4.1.2.2. Brain Aneurysms 5.4.1.2.3. Arteriovenous Malformations (AVMs) 5.4.1.2.4. Carotid Artery Stenosis 5.4.1.2.5. Others 5.4.1.3. United States Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 5.4.1.3.1. Hospitals and Clinics 5.4.1.3.2. Ambulatory Surgical Centers (ASCs) 5.4.1.3.3. Diagnostic Centers 5.4.1.3.4. Others 5.4.2. Canada 5.4.2.1. Canada Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 5.4.2.1.1. Cerebral Angiography Systems 5.4.2.1.2. Neurothrombectomy Devices 5.4.2.1.3. Embolic Coils and Flow Diverters 5.4.2.1.4. Carotid Stents and Embolic Protection Systems 5.4.2.1.5. Microcatheters and Balloon Catheters 5.4.2.1.6. Others 5.4.2.2. Canada Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 5.4.2.2.1. Ischemic Strokes 5.4.2.2.2. Brain Aneurysms 5.4.2.2.3. Arteriovenous Malformations (AVMs) 5.4.2.2.4. Carotid Artery Stenosis 5.4.2.2.5. Others 5.4.2.3. Canada Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 5.4.2.3.1. Hospitals and Clinics 5.4.2.3.2. Ambulatory Surgical Centers (ASCs) 5.4.2.3.3. Diagnostic Centers 5.4.2.3.4. Others 5.4.3. Mexico 5.4.3.1. Mexico Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 5.4.3.1.1. Cerebral Angiography Systems 5.4.3.1.2. Neurothrombectomy Devices 5.4.3.1.3. Embolic Coils and Flow Diverters 5.4.3.1.4. Carotid Stents and Embolic Protection Systems 5.4.3.1.5. Microcatheters and Balloon Catheters 5.4.3.1.6. Others 5.4.3.2. Mexico Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 5.4.3.2.1. Ischemic Strokes 5.4.3.2.2. Brain Aneurysms 5.4.3.2.3. Arteriovenous Malformations (AVMs) 5.4.3.2.4. Carotid Artery Stenosis 5.4.3.2.5. Others 5.4.3.3. Mexico Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 5.4.3.3.1. Hospitals and Clinics 5.4.3.3.2. Ambulatory Surgical Centers (ASCs) 5.4.3.3.3. Diagnostic Centers 5.4.3.3.4. Others 6. Europe Neurovascular Devices Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 6.1. Europe Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 6.2. Europe Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 6.3. Europe Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 6.4. Europe Neurovascular Devices Market Size and Forecast, by Country (2023-2030) 6.4.1. United Kingdom 6.4.1.1. United Kingdom Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 6.4.1.2. United Kingdom Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 6.4.1.3. United Kingdom Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 6.4.2. France 6.4.2.1. France Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 6.4.2.2. France Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 6.4.2.3. France Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 6.4.3. Germany 6.4.3.1. Germany Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 6.4.3.2. Germany Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 6.4.3.3. Germany Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 6.4.4. Italy 6.4.4.1. Italy Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 6.4.4.2. Italy Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 6.4.4.3. Italy Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 6.4.5. Spain 6.4.5.1. Spain Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 6.4.5.2. Spain Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 6.4.5.3. Spain Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 6.4.6. Sweden 6.4.6.1. Sweden Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 6.4.6.2. Sweden Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 6.4.6.3. Sweden Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 6.4.7. Austria 6.4.7.1. Austria Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 6.4.7.2. Austria Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 6.4.7.3. Austria Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 6.4.8. Rest of Europe 6.4.8.1. Rest of Europe Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 6.4.8.2. Rest of Europe Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 6.4.8.3. Rest of Europe Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 7. Asia Pacific Neurovascular Devices Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 7.1. Asia Pacific Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 7.2. Asia Pacific Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 7.3. Asia Pacific Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 7.4. Asia Pacific Neurovascular Devices Market Size and Forecast, by Country (2023-2030) 7.4.1. China 7.4.1.1. China Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 7.4.1.2. China Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 7.4.1.3. China Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 7.4.2. S Korea 7.4.2.1. S Korea Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 7.4.2.2. S Korea Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 7.4.2.3. S Korea Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 7.4.3. Japan 7.4.3.1. Japan Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 7.4.3.2. Japan Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 7.4.3.3. Japan Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 7.4.4. India 7.4.4.1. India Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 7.4.4.2. India Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 7.4.4.3. India Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 7.4.5. Australia 7.4.5.1. Australia Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 7.4.5.2. Australia Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 7.4.5.3. Australia Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 7.4.6. Indonesia 7.4.6.1. Indonesia Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 7.4.6.2. Indonesia Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 7.4.6.3. Indonesia Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 7.4.7. Malaysia 7.4.7.1. Malaysia Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 7.4.7.2. Malaysia Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 7.4.7.3. Malaysia Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 7.4.8. Vietnam 7.4.8.1. Vietnam Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 7.4.8.2. Vietnam Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 7.4.8.3. Vietnam Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 7.4.9. Taiwan 7.4.9.1. Taiwan Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 7.4.9.2. Taiwan Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 7.4.9.3. Taiwan Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 7.4.10. Rest of Asia Pacific 7.4.10.1. Rest of Asia Pacific Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 7.4.10.2. Rest of Asia Pacific Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 7.4.10.3. Rest of Asia Pacific Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 8. Middle East and Africa Neurovascular Devices Market Size and Forecast by Segmentation (by Value in USD Million) (2022-2029 8.1. Middle East and Africa Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 8.2. Middle East and Africa Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 8.3. Middle East and Africa Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 8.4. Middle East and Africa Neurovascular Devices Market Size and Forecast, by Country (2023-2030) 8.4.1. South Africa 8.4.1.1. South Africa Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 8.4.1.2. South Africa Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 8.4.1.3. South Africa Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 8.4.2. GCC 8.4.2.1. GCC Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 8.4.2.2. GCC Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 8.4.2.3. GCC Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 8.4.3. Nigeria 8.4.3.1. Nigeria Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 8.4.3.2. Nigeria Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 8.4.3.3. Nigeria Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 8.4.4. Rest of ME&A 8.4.4.1. Rest of ME&A Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 8.4.4.2. Rest of ME&A Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 8.4.4.3. Rest of ME&A Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 9. South America Neurovascular Devices Market Size and Forecast by Segmentation (by Value in USD Million) (2022-2029 9.1. South America Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 9.2. South America Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 9.3. South America Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 9.4. South America Neurovascular Devices Market Size and Forecast, by Country (2023-2030) 9.4.1. Brazil 9.4.1.1. Brazil Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 9.4.1.2. Brazil Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 9.4.1.3. Brazil Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 9.4.2. Argentina 9.4.2.1. Argentina Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 9.4.2.2. Argentina Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 9.4.2.3. Argentina Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 9.4.3. Rest Of South America 9.4.3.1. Rest Of South America Neurovascular Devices Market Size and Forecast, by Device Type (2023-2030) 9.4.3.2. Rest Of South America Neurovascular Devices Market Size and Forecast, by Application (2023-2030) 9.4.3.3. Rest Of South America Neurovascular Devices Market Size and Forecast, by End User (2023-2030) 10. Global Neurovascular Devices Market: Competitive Landscape 10.1. MMR Competition Matrix 10.2. Competitive Landscape 10.3. Key Players Benchmarking 10.3.1. Company Name 10.3.2. Service Segment 10.3.3. End-user Segment 10.3.4. Revenue (2022) 10.3.5. Company Locations 10.4. Leading Neurovascular Devices Market Companies, by Market Capitalization 10.5. Market Structure 10.5.1. Market Leaders 10.5.2. Market Followers 10.5.3. Emerging Players 10.6. Mergers and Acquisitions Details 11. Company Profile: Key Players 11.1. Medtronic plc (Dublin, Ireland) 11.1.1. Company Overview 11.1.2. Business Portfolio 11.1.3. Financial Overview 11.1.4. SWOT Analysis 11.1.5. Strategic Analysis 11.1.6. Scale of Operation (Small, Medium, and Large) 11.1.7. Recent Developments 11.2. Johnson & Johnson (New Brunswick, New Jersey, USA) 11.3. Stryker Corporation (Kalamazoo, Michigan, USA) 11.4. Terumo Corporation (Tokyo, Japan) 11.5. Abbott Laboratories (Abbott Park, Illinois, USA) 11.6. Penumbra, Inc. (Alameda, California, USA) 11.7. Merit Medical Systems, Inc. (South Jordan, Utah, USA) 11.8. Balt Extrusion (Montmorency, France) 11.9. Acandis GmbH (Pforzheim, Germany) 11.10. ArtVentive Medical Group, Inc. (Carlsbad, California, USA) 11.11. Spiegelberg GmbH & Co. KG (Hamburg, Germany) 11.12. EndoShape, Inc. (Aliso Viejo, California, USA) 11.13. Penumbra Europe GmbH (Alsbach-Hähnlein, Germany) 11.14. Terumo Corporation (Tokyo, Japan) 11.15. MicroPort Scientific Corporation (Shanghai, China) 11.16. Medikit Co., Ltd. (Tokyo, Japan) 11.17. Penumbra Japan (Tokyo, Japan) 11.18. Asahi Intecc Co., Ltd. (Aichi, Japan) 11.19. Kaneka Corporation (Osaka, Japan) 12. Key Findings 13. Industry Recommendations
  • INQUIRE BEFORE BUYING